A transforming growth factor beta 2 (TGF-beta 2)-like immunosuppressive factor in amniotic fluid and localization of TGF-beta 2 mRNA in the pregnant uterus.
This report describes a murine amniotic fluid (MAF) immunosuppressive factor that has properties similar to transforming growth factor beta (TGF-beta). The MAF factor exhibits TGF-beta-like activity in stimulating soft agar colony formation by AKR-2B cells and inhibiting thymidine uptake by Mv1Lu cells. We demonstrate that both the immunosuppressive and TGF-beta-like activities of the MAF factor are completely neutralized by anti-TGF-beta 2-specific antibodies and not by anti-TGF-beta 1-specific antisera. The immunosuppressive factor in MAF is novel in that it appears to be identical or very closely related to TGF-beta 2 and is active in its native state. This active and anti-TGF-beta 2-neutralizable factor chromatographs at approximately 70 kD on Sephadex at neutral pH and appears to be able to complex with alpha-fetoprotein in native amniotic fluid. Chromatography of native MAF under acidic conditions demonstrates a lower molecular mass protein that chromatographs on BioGel in the same position as the mature 25-kD TGF-beta. This protein has the biological properties of TGF-beta and is immunosuppressive. Both of these activities are neutralizable with anti-TGF-beta 2 but not with anti-TGF-beta 1 or other antisera. By Northern analysis, we find high levels of TGF-beta 2 mRNA (with little or no TGF-beta 1) in the pregnant uterus that peak around day 15 of gestation and then fall rapidly by day 19 as birth approaches. The TGF-beta 2-like factor could possibly play a role in maternal immunity, in the retention of the fetal allograft, as well as in regulating fetal and neonatal immunological competence.
Department of Molecular Medicine and Immunology, Roswell Park Cancer Institute, Buffalo, New York 14263.
D J
DJ
Altman
S L
SL
Schneider
D A
DA
Thompson
H L
HL
Cheng
T B
TB
Tomasi
D000653:Amniotic Fluid / Q000737:chemistry* / Q000378:metabolism; D000818:Animals; D000831:Animals, Newborn / Q000276:immunology / Q000378:metabolism; D015152:Blotting, Northern; D002850:Chromatography, Gel / Q000379:methods; D003115:Colony-Stimulating Factors / Q000032:analysis; D005260:Female; D005333:Fetus / Q000276:immunology / Q000378:metabolism; D007166:Immunosuppressive Agents / Q000032:analysis*; D051379:Mice; D011247:Pregnancy; D012333:RNA, Messenger / Q000032:analysis* / Q000235:genetics / Q000378:metabolism; D016212:Transforming Growth Factor beta / Q000032:analysis* / Q000235:genetics / Q000378:metabolism / Q000502:physiology; D014599:Uterus / Q000737:chemistry* / Q000378:metabolism; D000509:alpha-Fetoproteins / Q000378:metabolism
D003115:Colony-Stimulating Factors; D007166:Immunosuppressive Agents; D012333:RNA, Messenger; D016212:Transforming Growth Factor beta; D000509:alpha-Fetoproteins